A Comparison of the Influence of a High-fat Diet Enriched in Monounsaturated Fatty Acids and Conventional Diet on Weight Loss and Metabolic Parameters in Obese Non-diabetic and Type 2 Diabetic Patients
Overview
Authors
Affiliations
Aims: The aim of our study was to compare the influence of a hypocaloric, high-fat diet enriched with MUFA (M) and conventional diet (C) on weight loss and metabolic parameters in obese non-diabetic and obese Type 2 diabetic subjects over a 3-month period. It was our hypothesis that the enriched diet would be more effective in decreasing blood glucose and glycated haemoglobin (HbA(1c)) than the control diet.
Methods: Twenty-seven Type 2 diabetic patients (54.5 +/- 3.5 years; DM), treated with diet or oral glucose-lowering agents, and 31 obese non-diabetic subjects (53.6 +/- 3.5 years; OB) were randomized to M or C. Individual calculations of energy requirements were based on the formula: [resting energy expenditure (REE) x 1.5] - 600 kcal. Subjects were assessed by a dietitian every 2 weeks and by a physician every month. Statistical analyses were carried out between the four groups--DM/M, DM/C, OB/M and OB/C--using pair Student's test and anova.
Results: After 3 months, body weight, waist-hip ratio, total body fat, levels of C-peptide, triglycerides and homeostasis model assessment (HOMA) decreased in all four groups (P < 0.01). However, fasting blood glucose and HbA(1c) decreased (P < 0.01) and high-density lipoprotein cholesterol increased significantly only in the DM/M group (P < 0.05). In general, M was well tolerated.
Conclusions: Individualized M and C diets were successful in improving metabolic and anthropometric parameters in both the obese non-diabetic and the Type 2 diabetic subjects. Although the superiority of the higher fat diet did not reach statistical significance, the decline in blood glucose and HbA(1c) in the Type 2 diabetic group on M was encouraging.
Braun T, Drobner T, Kipp K, Kiehntopf M, Schlattmann P, Lorkowski S Nutrients. 2024; 16(9).
PMID: 38732508 PMC: 11085300. DOI: 10.3390/nu16091261.
Diabetes Care. 2023; 47(Suppl 1):S77-S110.
PMID: 38078584 PMC: 10725816. DOI: 10.2337/dc24-S005.
Sikand G, Handu D, Rozga M, de Waal D, Wong N Curr Atheroscler Rep. 2023; 25(6):331-342.
PMID: 37165278 PMC: 10171906. DOI: 10.1007/s11883-023-01096-0.
Zeng B, Pan H, Li F, Ye Z, Liu Y, Du J J Diabetes Investig. 2022; 14(2):263-288.
PMID: 36514864 PMC: 9889690. DOI: 10.1111/jdi.13935.
ElSayed N, Aleppo G, Aroda V, Bannuru R, Brown F, Bruemmer D Diabetes Care. 2022; 46(Supple 1):S68-S96.
PMID: 36507648 PMC: 9810478. DOI: 10.2337/dc23-S005.